Moderna explores outside financing for vaccine trials, shares dip
Go back to Moderna explores outside financing for vaccine trials, shares dip| THE BLACKSTONE GROUP L.P (NYSE: BX) | Delayed: 120.59 -3.42 (2.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.01 | 52 Week High | $32.07 | |||
| Open | $121.83 | 52 Week Low | $22.31 | |||
| Day High | $122.48 | P/E | 106.72 | |||
| Day Low | $118.76 | EPS | $1.13 | |||
| Volume | 2,991,411 | |||||
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 184.84 +2.28 (1.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $182.56 | 52 Week High | $0.52 | |||
| Open | $183.41 | 52 Week Low | $0.08 | |||
| Day High | $192.31 | P/E | N/A | |||
| Day Low | $182.60 | EPS | $-3.80 | |||
| Volume | 12,828,317 | |||||
